  In cancer research, high-throughput profiling has been extensively conducted.
In recent studies, the integrative analysis of data on multiple cancer patient
groups/subgroups has been conducted. Such analysis has the potential to reveal
the genomic commonality as well as difference across groups/subgroups. However,
in the existing literature, methods with a special attention to the genomic
commonality and difference are very limited. In this study, a novel estimation
and marker selection method based on the sparse boosting technique is developed
to address the commonality/difference problem. In terms of technical
innovation, a new penalty and computation of increments are introduced. The
proposed method can also effectively accommodate the grouping structure of
covariates. Simulation shows that it can outperform direct competitors under a
wide spectrum of settings. The analysis of two TCGA (The Cancer Genome Atlas)
datasets is conducted, showing that the proposed analysis can identify markers
with important biological implications and have satisfactory prediction and
stability.
